Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.
- DOI
- 10.3413/nukmed-0322-10-06
- Published
- 2011
- Container
- Nuklearmedizin. Nuclear medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3413/nukmed-0322-10-06,
title = {Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.},
author = {Grgic A and Nestle U and Scheidhauer K and Puskas C and Ballek E and Hohloch K and Schubert J and König J and Pinkert J and Truemper L and Hellwig D and Kirsch CM},
year = {2011},
journal = {Nuklearmedizin. Nuclear medicine},
doi = {10.3413/nukmed-0322-10-06},
url = {https://doi.org/10.3413/nukmed-0322-10-06}
}RIS
TY - JOUR TI - Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma. AU - Grgic A AU - Nestle U AU - Scheidhauer K AU - Puskas C AU - Ballek E AU - Hohloch K AU - Schubert J AU - König J AU - Pinkert J AU - Truemper L AU - Hellwig D AU - Kirsch CM PY - 2011 JO - Nuklearmedizin. Nuclear medicine DO - 10.3413/nukmed-0322-10-06 UR - https://doi.org/10.3413/nukmed-0322-10-06 ER -
APA
A, G., U, N., K, S., C, P., E, B., K, H., J, S., J, K., J, P., L, T., D, H., & CM, K. (2011). Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.. Nuklearmedizin. Nuclear medicine. https://doi.org/10.3413/nukmed-0322-10-06
Source records
- pubmed · retrieved 2026-09-26T06:50:58.693Z